Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States

By sjmartinez • January 7, 2023

Nicholas SB, Alicic RZ, Shen J. Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States. Kidney Med. 2022 Dec 15;5(1):100590. doi: 10.1016/j.xkme.2022.100590. PMID: 36605084; PMCID: PMC9807823.

Tags: Harbor UCLA, Nephrology, Publications

Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes

Hamad CD, Wiener J, Golzar A, Kaur H, Henein C, Kittredge AP, Su G, Kaelber DC, Chan L, Yeaman MR, Adams JS, Bernthal NM, Sheppard[...]

Association of Low-Attenuation Noncalcified Plaque Shape and Degree of Intraplaque Embeddedness Using Atherosclerotic Imaging-enabled Quantitative CT with Acute Coronary Syndrome

Malkasian S, Nurmohamed NS, Chang HJ, Choi AD, Marques H, Molloi S, van Rosendael A, Chow BJW, Andreini D, Conte E, Maffei E, Plank F,[...]

Hidradenitis in Pediatrics

Dhillon S, Horneck N, Smogorzewski J. Hidradenitis in Pediatrics. Adv Pediatr. 2026 Aug;73(1):295-307. doi: 10.1016/j.yapd.2025.12.007. Epub 2026 May 21. PMID: 42481098.